Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 1/20 | 0.65 |
| ▸ | CPT2 | P23786 | 1/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | HMGCR | P04035 | 1/20 | 0.48 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.48 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.45 |
| ▸ | BHMT | Q93088 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15074709 | 0.88 | FFAR1 (0.52) | FFAR1CPT2TDP1KDM4EHMGCR | |
| SCHEMBL2999282 | 0.86 | FFAR1 (0.75) | FFAR1CPT2TDP1KDM4EHMGCR | |
| SCHEMBL11529406 | 0.86 | NAALAD2 (0.50) | FFAR1CPT2TDP1KDM4EHMGCR | |
| SCHEMBL5302072 | 0.85 | TDP1 (0.74) | FFAR1CPT2TDP1KDM4EHMGCR | |
| SCHEMBL3280409 | 0.85 | FFAR1 (0.60) | FFAR1CPT2TDP1KDM4EHMGCR | |
| Hydrochloric Acid SCHEMBL31279551 | 0.83 | NAALAD2 (0.48) | FFAR1CPT2TDP1KDM4EHMGCR | |
| Sebacic Acid SCHEMBL28078194 | 0.83 | TDP1 (0.71) | FFAR1CPT2TDP1KDM4EADRA1A | |
| SCHEMBL12056017 | 0.82 | FFAR1 (0.62) | FFAR1CPT2TDP1KDM4EHMGCR | |
| SCHEMBL14360742 | 0.81 | TDP1 (0.83) | FFAR1CPT2TDP1KDM4EADRA1A | |
| SCHEMBL2496692 | 0.81 | TDP1 (0.83) | FFAR1CPT2TDP1KDM4EADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 280 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150259311-A1 | METHOD OF PRODUCING LACTONE FROM HYDROXYCARBOXYLIC ACID OR DICARBOXYLIC ACID IN AQUEOUS SOLUTION | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2015-09-17 | — | — | US | claimed |
| US-20130204015-A1 | PROCESS FOR PREPARING A LACTONE | RHODIA OPERATIONS (FR) | 2013-08-08 | — | — | US | claimed |
| CN-102834172-A | Method for preparing a lactone | RHODIA OPERATIONS | 2012-12-19 | — | — | CN | claimed |
| CN-102702940-A | Floating coating for automobile | TIANCHANG JULONG TRAVEL PAINT CO LTD | 2012-10-03 | — | — | CN | claimed |
| US-5856581-A | DECARBOXYLATING/CYCLIZING A DICARBOXYLIC ACID, IN LIQUID PHASE, IN THE PRESENCE OF A CATALYTICALLY EFFECTIVE AMOUNT OF A METAL OR COMPOUND COMPOUND THEREOF SELECTED FROM AMONG BORON, ALUMINUM, GALLIUM, INDIUM, THALLIUM, TIN, ANTIMONY, | RHONE-POULENC CHIMIE (FR) | 1999-01-05 | — | — | US | claimed |
| EP-0626364-B1 | Process for the preparation of a cyclic ketone | RHONE POULENC CHIMIE (FR) | 1998-04-08 | — | — | EP | claimed |
| EP-0626363-B1 | Process for the préparation of a cyclic ketone | RHONE POULENC CHIMIE (FR) | 1998-03-04 | — | — | EP | claimed |
| US-5600013-A | CATALYTIC CARBOXYLATION AND CYCLIZATION OF DICARBOXYLIC ACIDS | RHONE-POULENC CHIMIE (FR) | 1997-02-04 | — | — | US | claimed |
| EP-4514769-B1 | MUSKY ODORANT | FIRMENICH & CIE (CH) | 2026-04-15 | — | — | EP | disclosed |
| US-20250263629-A1 | MUSKY ODORANT | FIRMENICH SA (CH) | 2025-08-21 | — | — | US | disclosed |
| EP-4514769-A1 | MUSKY ODORANT | Firmenich SA (CH) | 2025-03-05 | — | — | EP | disclosed |
| CN-119095821-A | Musk odorants | 弗门尼舍有限公司 | 2024-12-06 | — | — | CN | disclosed |
| EP-3356345-B1 | HETEROARYL DERIVATIVES AS SEPIAPTERIN REDUCTASE INHIBITORS | MAX PLANCK GESELLSCHAFT (DE) | 2023-11-08 | — | — | EP | disclosed |
| EP-3356345-B1 | HETEROARYL DERIVATIVES AS SEPIAPTERIN REDUCTASE INHIBITORS | MAX PLANCK GESELLSCHAFT (DE) | 2023-11-08 | — | — | EP | disclosed |
| WO-2006035061-A1 | HCV INHIBITING BI-CYCLIC PYRIMIDINES | TIBOTEC PHARMACEUTICALS LTD. (IE) | 2006-04-06 | — | — | WO | disclosed |
| EP-1608631-A2 | BI-CYCLIC PYRIMIDINE INHIBITORS OF TGF BETA | SCIOS INC. (US) | 2005-12-28 | — | — | EP | disclosed |
| US-20050004143-A1 | Bi-cyclic pyrimidine inhibitors of TGFbeta | SCIOS, INC. | 2005-01-06 | — | — | US | disclosed |
| WO-2004087056-A2 | BI-CYCLIC PYRIMIDINE INHIBITORS OF TGFβ | SCIOS INC. (US) | 2004-10-14 | — | — | WO | disclosed |
| US-5856581-A | DECARBOXYLATING/CYCLIZING A DICARBOXYLIC ACID, IN LIQUID PHASE, IN THE PRESENCE OF A CATALYTICALLY EFFECTIVE AMOUNT OF A METAL OR COMPOUND COMPOUND THEREOF SELECTED FROM AMONG BORON, ALUMINUM, GALLIUM, INDIUM, THALLIUM, TIN, ANTIMONY, | RHONE-POULENC CHIMIE (FR) | 1999-01-05 | — | — | US | disclosed |
| US-5600013-A | CATALYTIC CARBOXYLATION AND CYCLIZATION OF DICARBOXYLIC ACIDS | RHONE-POULENC CHIMIE (FR) | 1997-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130204015-A1 | PROCESS FOR PREPARING A LACTONE | HSD17B7, HSD17B3, RPS3 | FFAR1 3056/4885CPT2 1757/4885TDP1 4802/4885 |
| US-20250263629-A1 | MUSKY ODORANT | TRPA1, MSMO1, MSH2 | FFAR1 250/4885CPT2 635/4885TDP1 2647/4885 |
| US-20050004143-A1 | Bi-cyclic pyrimidine inhibitors of TGFbeta | TYMP, TYMS, TGFBR1 | FFAR1 3969/4885CPT2 4310/4885TDP1 105/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.